CLINICAL TRIALS PROFILE FOR SULFACETAMIDE SODIUM
✉ Email this page to a colleague
All Clinical Trials for SULFACETAMIDE SODIUM
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01369641 ↗ | The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy | Terminated | Sidney Kimmel Cancer Center at Thomas Jefferson University | N/A | 2011-08-24 | This is a pilot, randomized, self-controlled study of the effects of intratympanic sodium thiosulfate (STS) on the degree of hearing loss in patients receiving cisplatin therapy. Sodium thiosulfate is an inactive ingredient contained in sulfacetamide ophthalmic solution which is used routinely as an otic solution delivered to the middle ear space. The hypothesis of this study is that local administration of sodium thiosulfate (STS) will result in improved hearing compared to ears not receiving the study drug in patients receiving systemic cisplatin therapy. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SULFACETAMIDE SODIUM
Condition Name
Clinical Trial Locations for SULFACETAMIDE SODIUM
Trials by Country
Clinical Trial Progress for SULFACETAMIDE SODIUM
Clinical Trial Phase
Clinical Trial Sponsors for SULFACETAMIDE SODIUM
Sponsor Name